中國星(00326.HK)遭證監會點名股權高度集中
證監會表示,最近就中國星(00326.HK)的股權分佈進行查訊,結果顯示截至今年6月27日,該公司共有19名股東及相關人士合共持有近5.79億股股份(相當於已發行股本23.83%),另有逾16.4億股(佔已發行股本67.54%)由公司主席及副主席持有。上述有關股權合計已相當於中國星發行股本的91.37%。
換言之,應星控股於6月27日只有近2.1億股(佔已發行股本8.63%)是由其他股東持有,屬股權集中於極少數股東手中。證監會指出,由於股權高度集中於數目不多的股東,即使少量股份成交,其股價亦可能大幅波動,提醒股東及有意投資者買賣時務請審慎行事。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.